Menzies School of Health Research   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Darwin Australia (1984)

Organization Overview

First Clinical Trial
1996
NCT00539149
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Menzies School of Health Research | Menzies School of Health Research, Darwin, Australia | Menzies School of Health Research, Northern Territory, Australia | Menzies School of Helath Research | Menzies School of Research

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Ear Diseases (Phase 3)

Gastroenteritis (Phase 4)

Infections (Phase 4)

Korsakoff Syndrome (Phase 4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Malaria, Vivax (Phase 4)

Otitis (Phase 4)

Otitis Media (Phase 4)

Otitis Media with Effusion (Phase 4)

Pneumococcal Infections (Phase 3)

Pneumonia (Phase 4)

Respiratory Tract Infections (Phase 4)

Syndrome (Phase 4)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 3)

Tympanic Membrane Perforation (Phase 3)

Wernicke Encephalopathy (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 36
  • # of Trial APIs: 32